Patient with an Autoimmune Disease

  • Neeraj EdwardEmail author
  • Harsh Sachdeva


There are almost 100 distinct autoimmune diseases that have been discovered at this time, some of which can cause significant pain. Autoimmune disease can be a challenge in inpatient management given the complex nature of the myriad of disorders. While in the hospital, these disorders can be challenging to treat. This chapter will focus on some of the more common autoimmune diseases and the diagnosis and treatment in the hospital setting. A short introduction to the specific pathophysiology and diagnosis of the most common disorders will be followed by a discussion of treatment. The focus will be on established and novel treatments for “flares” that often occur in these patients and can be the focus of hospitalization. Challenges to pain control will also be discussed including interactions with autoimmune drug treatments. Finally, this chapter will lightly touch on the pain assessment tools relevant to these diseases and then focus on challenges in treatment and transition of care.


Autoimmune disease Rheumatoid arthritis Systemic lupus erythematosus Crohn’s disease Ulcerative colitis Inflammatory bowel disease Neuromodulation Musculoskeletal pain Abdominal pain 


  1. 1.
    Wang L, Wang FS, Gershwin ME. Human autoimmune diseases: a comprehensive update. J Intern Med. 2015;278(4):369–95. Epub 2015 Jul 25.CrossRefGoogle Scholar
  2. 2.
    Cooper GS, Bynum ML, Somers EC. Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases. J Autoimmun. 2009;33(3–4):197–207. Epub 2009 Oct 9.CrossRefGoogle Scholar
  3. 3.
    Cooper GS, Stroehla BC. The epidemiology of autoimmune diseases. Autoimmun Rev. 2003;2(3):119–25.CrossRefGoogle Scholar
  4. 4.
    Mifflin KA, Kerr BJ. Pain in autoimmune disorders. J Neurosci Res. 2017;95(6):1282–94. Epub 2016 Jul 22.CrossRefGoogle Scholar
  5. 5.
    Scholz J, Woolf CJ. The neuropathic pain triad: neurons, immune cells and glia. Nat Neurosci. 2007;10(11):1361–8.CrossRefGoogle Scholar
  6. 6.
    Wasserman AM. Diagnosis and management of rheumatoid arthritis. Am Fam Physician. 2011;84(11):1245–52.PubMedGoogle Scholar
  7. 7.
    Zhang Y-Z, Li Y-Y. Inflammatory bowel disease: pathogenesis. World J Gastroenterol. 2014;20(1):91–9.CrossRefGoogle Scholar
  8. 8.
    Di Franco M, Guzzo MP, Spinelli FR, Atzeni F, Sarzi-Puttini P, Conti F, Iannuccelli C. Pain and systemic lupus erythematosus. Reumatismo. 2014;66(1):33–8.CrossRefGoogle Scholar
  9. 9.
    Robinson AB, Reed AM. Clinical features, pathogenesis and treatment of juvenile and adult dermatomyositis. Nat Rev Rheumatol. 2011;7(11):664–75.CrossRefGoogle Scholar
  10. 10.
    Wasserman AM. Rheumatoid arthritis: common questions about diagnosis and management. Am Fam Physician. 2018;97(7):455–62.PubMedGoogle Scholar
  11. 11.
    Sairenji T, Collins KL, Evans DV. An update on inflammatory bowel disease. Prim Care. 2017;44(4):673–92. Epub 2017 Oct 5.CrossRefGoogle Scholar
  12. 12.
    Roy MA. Endoscopic diagnosis of inflammatory bowel disease. In: Post TW, editor. UpToDate. Waltham: UpToDate Inc. Accessed 9 Sept 2019.
  13. 13.
    Yu C, Gershwin ME, Chang C. Diagnostic criteria for systemic lupus erythematosus: a critical review. J Autoimmun. 2014;48–49:10–3. Epub 2014 Jan 21.CrossRefGoogle Scholar
  14. 14.
    Miller ML. Diagnosis and differential diagnosis of dermatomyositis and polymyositis in adults. In: Post TW, editor. UpToDate. Waltham: UpToDate Inc. Accessed 30 Aug 2019.
  15. 15.
    Mahmoud TG, Huang J, Frits M, Iannaccone C, Bykerk V, Bingham CO 3rd, Weinblatt M, Shadick NA. Correlates of successful rheumatoid arthritis flare management: clinician-driven treatment, home-based strategies, & medication change. J Rheumatol. 2019. pii: jrheum.181160.Google Scholar
  16. 16.
    Pan B, Zhang Z, Chao D, Hogan QH. Dorsal root ganglion field stimulation prevents inflammation and joint damage in a rat model of rheumatoid arthritis. Neuromodulation. 2018;21(3):247–53. Epub 2017 Sep 5.CrossRefGoogle Scholar
  17. 17.
    Kanashiro A, Shimizu Bassi G, de Queiróz Cunha F, Ulloa L. From neuroimunomodulation to bioelectronic treatment of rheumatoid arthritis. Bioelectron Med (Lond). 2018;1(2):151–65.CrossRefGoogle Scholar
  18. 18.
    Liu MH, Tian J, Su YP, Wang T, Xiang Q, Wen L. Cervical sympathetic block regulates early systemic inflammatory response in severe trauma patients. Med Sci Monit. 2013;19:194–201.CrossRefGoogle Scholar
  19. 19.
    Zhao HY, Yang GT, Sun NN, Kong Y, Liu YF. Efficacy and safety of stellate ganglion block in chronic ulcerative colitis. World J Gastroenterol. 2017;23(3):533–9.CrossRefGoogle Scholar
  20. 20.
    Norton C, Czuber-Dochan W, Artom M, Sweeney L, Hart A. Systematic review: interventions for abdominal pain management in inflammatory bowel disease. Aliment Pharmacol Ther. 2017;46(2):115–25. Epub 2017 May 4.CrossRefGoogle Scholar
  21. 21.
    Waldheim E, Ajeganova S, Bergman S, Frostegård J, Welin E. Variation in pain related to systemic lupus erythematosus (SLE): a 7-year follow-up study. Clin Rheumatol. 2018;37(7):1825–34. Epub 2018 Apr 14.CrossRefGoogle Scholar
  22. 22.
    Kennedy JW, Khan W. Total hip arthroplasty in systemic lupus erythematosus: a systematic review. Int J Rheumatol. 2015;2015:475489. Epub 2015 Jul 8.CrossRefGoogle Scholar
  23. 23.
    Hengstman GJ, van den Hoogen FH, van Engelen BG. Treatment of the inflammatory myopathies: update and practical recommendations. Expert Opin Pharmacother. 2009;10(7):1183–90.CrossRefGoogle Scholar
  24. 24.
    Chen KL, Zeidi M, Werth VP. Recent advances in pharmacological treatments of adult dermatomyositis. Curr Rheumatol Rep. 2019;21(10):53.CrossRefGoogle Scholar
  25. 25.
    Sigmund A, Russell LA. Optimizing rheumatoid arthritis patients for surgery. Curr Rheumatol Rep. 2018;20(8):48.CrossRefGoogle Scholar
  26. 26.
    Somers EC, Lee J, Hassett AL, Zick SM, Harlow SD, Helmick CG, Barbour KE, Gordon C, Brummett CM, Minhas D, Padda A, Wang L, McCune WJ, Marder W. Prescription opioid use in patients with and without systemic lupus erythematosus—Michigan Lupus Epidemiology and Surveillance Program, 2014-2015. MMWR Morb Mortal Wkly Rep. 2019;68(38):819–24.CrossRefGoogle Scholar
  27. 27.
    Alley K, Singla A, Afzali A. Opioid use is associated with higher health care costs and emergency encounters in inflammatory bowel disease. Inflamm Bowel Dis. 2019;14;25(12):1990–5.CrossRefGoogle Scholar
  28. 28.
    Dansie EJ, Turk DC. Assessment of patients with chronic pain. Br J Anaesth. 2013;111(1):19–25.CrossRefGoogle Scholar
  29. 29.
    Lazaridou A, et al. Chapter 5: Pain assessment. In: Benzon H, Raja SN, Fishman SM, Liu SS, Cohen SP, editors. Essentials of pain medicine. 4th ed. Philadelphia: Elsevier; 2017. p. 39–45.Google Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Department of Anesthesiology and Pain ManagementUniversity of Cincinnati Medical CenterCincinnatiUSA

Personalised recommendations